Biotech Values

[DewDiligence]

“Once is happenstance, twice is coincidence, three times is enemy action, Mr. Bond.” *

1. Zetia showed no clinical benefit when added to Zocor in the ENHANCE study, despite raising HDL the way it was supposed to (#msg-25991228).

2. TriCor failed to show a statsig benefit when added to Zocor in the ACCORD study, despite lowering triglycerides and raising HDL the way it was supposed to (#msg-47808450).

3. Niaspan showed no clinical benefit when added to Zocor in the AIM-HIGH study, despite raising HDL the way it was supposed to (#msg-63617748).


We have enemy action.

*From Goldfinger.